Dr. Carol Erin Cheng, MD

Dr. Cheng practices at Santa Monica Surgicenter in Santa Monica, California.

Dr. Cheng's NPI, 1285911453, was assigned on November 15, 2011. Dr. Cheng graduated from Boston University School Of Medicine in 2011. Dr. Cheng holds California license A136066.

Dr. Cheng's primary practice is Santa Monica Surgicenter, at 2001 Santa Monica Blvd, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 829-5550.

Dr. Cheng's primary practice is Santa Monica Surgicenter in Santa Monica, California. The medical group on file is Harbor-UCLA Medical Center. Dmand AI also links Dr. Cheng to 2 more group practices and clinics, 2 medical groups and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheng practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Cheng's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Cheng is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Cheng's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists acne, benign or precancerous skin growths, contact dermatitis, corns and calluses, scalp rash and skin cyst among the conditions Dr. Cheng treats.

CMS data shows 145 Medicare services from Dr. Cheng across 3 procedure codes in 2024, for 61 Medicare patients. Medicare paid $14,577 for them. Every service was in an office.

CMS counts 61 Medicare patients who saw Dr. Cheng in 2024. The largest group is 65 to 74, with 24 patients. 70% of them have high cholesterol, and 61% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cheng's median patient age at 15, with 55% women.

In 2024, Dr. Cheng wrote 62 Medicare Part D claims for 27 patients. 90% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $138 in total drug cost. In 2023, CMS named 27 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Cheng for performance year 2024, reported as part of a group. Dr. Cheng accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of removal of skin lesions by Dr. Cheng, more than 61% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 31 papers to Dr. Cheng, published from 2010 to 2024. 2019 was the busiest year, with 4. The most frequent topics are Acne Vulgaris, Skin and Skin Neoplasms. Dr. Cheng has published most often in Pediatr Dermatol. Dr. Cheng's most frequent co-authors are Marcia Hogeling, MD, Hannah Sophie Berman, MD and Victoria Regina Barrio, MD.

CMS Open Payments shows 36 general payments to Dr. Cheng from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Abbvie Inc. paid the most, $409.

Dmand AI lists 1 award for Dr. Cheng, most recently AOA Inductee 2011 in 2011.

Dr. Cheng graduated from Boston University School Of Medicine in 2011. Dr. Cheng is a member of AOA.

Dr. Cheng is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.